x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

49:24

Founding and selling three bio CDMOs - Part 1

Molecule to Market: Inside the outsourcing space ·

2023/02/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Bamforth, Entrepreneur, Mentor and Investor in life sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mark, covering: Mark’s backstory from oil barrels to brewing, to a small biotech called... Genzyme A baptism of fire of having to raise money for a self-funded CDMO carve-out after 22 years in the corporate world How a merger

en

23:24

Network like a pro

Molecule to Market: Inside the outsourcing space ·

2023/02/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal, covering his top tips for networking ahead of this year’s events season after two decades of learning the do's and dont's, and making the mistakes for you. This episode covers; The importance of networking and how vital human interaction is to keep business going Being your own brand and understanding your network is your net worth Judging a book by its cover, and

en

29:53

Diversity in life sciences

Molecule to Market: Inside the outsourcing space ·

2023/02/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal for a special lookback episode on the topic of diversity in the life sciences space. This week’s episode features excerpts from conversations with; Barbara Morgan (Lubrizol at time of recording), now Global Vice President, Pharma and Biotechnology at Kerry discussing; gender diversity and the network of women supporting each other in their roles. Tia Lyles-Williams,

en

47:53

The CDMO CEO on the frontline of a Covid mission

Molecule to Market: Inside the outsourcing space ·

2023/02/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tom Ross, President and CEO at Grand River Aseptic Manufacturing (GRAM). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, covering: How a passive investment in a small growing business led to running one of the most reputable CDMOs in the US Insights of how to pivot from lumpy clinical supply to sustainable commercial revenues

en

51:18

Industry insights you cannot afford to miss

Molecule to Market: Inside the outsourcing space ·

2023/01/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ian Tzeng, Managing Director at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ian, covering: Insights, trends and advice for CROs, CDMOs and pharma services firms from one of the most prominent life science consultants. What he gained from his time studying at Harvard and the importance of genuine curiosity and a

en

47:43

The Puzzle-Solving Lifelong Science Geek

Molecule to Market: Inside the outsourcing space ·

2023/01/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Aldridge, Chief Strategy Officer at Form Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering: How a family ritual of solving puzzles played a role in developing an entrepreneurial spirit of problem solving Learn about how and why Northern Texas is becoming a destination for biotech and life sciences Going viral for

en

44:48

The CDMO with a capital D

Molecule to Market: Inside the outsourcing space ·

2023/01/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Harry Christiaens, CEO at Ardena. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Harry, covering: How a regulatory change led a small consultancy down the path of becoming one of Europe’s most respected mid-sized CDMOs The easy-theory of an M&A buy-and-build strategy, versus the challenging practical realities after acquiring and

en

58:01

100 episodes of Molecule to Market: looking back,...

Molecule to Market: Inside the outsourcing space ·

2023/01/06

In this special episode of Molecule to Market, we are marking our 100th episode! Join us as we look back, review our learnings and lay the land for episode 101… For those that have been here since the beginning, we are incredibly grateful for your constant support and feedback. To our new listeners, thank you for joining the journey, seeing us through to 30,000 downloads and beyond. To our guests - thank you for being a part of this experience with us and taking the time to share your story. The

en

22:52

Raman’s review of life science in 2022

Molecule to Market: Inside the outsourcing space ·

2022/12/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the last 12 months in the life science industry. He covers his 5 key trends from the year including: The biotech capital market slowdown and its impact on the outsourcing space Sustainability as the hot topic within the sector, from events to company practices Businesses operating in an increasingly digital way and what that means for

en

20:01

A blast from the life science past

Molecule to Market: Inside the outsourcing space ·

2022/12/23

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with a look back to some of our early guests from the Molecule to Market archive. Your host, Raman Sehgal, recaps his discussions on the pharmaceutical and biotechnology supply chain with: Stefano Console, founder and Senior Advisor at Oriento discussing: founding his business in Switzerland and the fractional management staffing structure that is helping Oriento succeed Claire

en

39:48

Tackling the 3 Big C’s: CDMO Career, Children & Cancer

Molecule to Market: Inside the outsourcing space ·

2022/12/16

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sarah Stevens, SVP and Head of Early Development & Late Stage Commercial Operations at Quotient Sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sarah, covering: Carving an incredible transatlantic CDMO career in traditionally non-female roles - balancing work, kids and breast cancer. Words of wisdom for young women developing

en

45:06

Mystic Miller’s review of ’22 and predictions for ’23

Molecule to Market: Inside the outsourcing space ·

2022/12/09

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with independent life sciences consultant Jim Miller. Your host, Raman Sehgal sits down with Jim covering: The three biggest macro factors impacting the CDMO space right now How CDMOs and CROs are starting to feel the pain of emerging biotech’s funding woes What we can learn from the 08-09 financial crash that can help CDMOs/CROs during rockier financial times The cooling of M&A and

en

34:03

Top 5 episodes of all time

Molecule to Market: Inside the outsourcing space ·

2022/11/18

As we celebrate the podcast hitting 30,000 downloads and approaching its 100th episode, Raman reflects on the most downloaded episodes with highlights from the top 5. In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector, diving into the top 5 episodes of all time, featuring: JoyL Silva, Pfizer CentreOne discussing: her early career journey and advice, industry trends, and personalized medicines Tia Lyles-Williams, LucasPye Bio

en

23:59

CPHI 2022 - Trends, challenges & opportunities

Molecule to Market: Inside the outsourcing space ·

2022/11/11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses emerging trends and challenges for the life sciences sector live from CPHI Frankfurt 2022, with: Grainne Hughes, Vice President of Business Support Operations at Almac Christine Fürst, Senior Director Key Account Manager Europe at Vetter Pharma Guido Wallraff, Corporate Business Development Director at Ardena Jenny Gattari, CDMO Business

en

15:13

Views from AAPS 2022

Molecule to Market: Inside the outsourcing space ·

2022/10/28

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses future industry trends live from AAPS Boston 2022, with: Casey Franklin, VP of Business Development at Alcami Umberto Romeo, R&D Manager at Corden Pharma Steven Dodd, Executive Director for sales strategy at Icon CRO Paul Dickinson, Founder & CSO at Seda Pharmaceutical Development Services Raman finds out more about the

en

50:10

The Personalized Medicine Pioneer

Molecule to Market: Inside the outsourcing space ·

2022/10/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Katz, Founder & CSO at Sparrow Pharmaceuticals, Inc.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering: The contrast of developing new drugs and running clinical trials in a big pharma versus his journey as the founder of a virtual biopharma company. What life really looks like and skills you have to develop in a firm

en

45:34

Inizio’s biotech bromance

Molecule to Market: Inside the outsourcing space ·

2022/10/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason McKenna, Global President, and Dean McAlister, Executive Vice President both from Inizio Biotech. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with the dynamic duo, covering: A wealth of big pharma learnings for today’s emerging biotechs. The (good and bad) impact of the current biotech capital market slowdown on decision-making for

en

53:03

The Magic of Drug Development

Molecule to Market: Inside the outsourcing space ·

2022/09/29

In this special episode of Molecule to Market, we go back inside the global drug development space with Marcelo Bigal, President and CEO, of Ventus Therapeutics, and Versant Venture Partner, who shares his journey from being a neurologist to taking a drug to market when he became part of Teva Pharmaceuticals and now is a CEO. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Marcelo, covering: What it feels like to take a drug from the laboratory to market

en

35:25

Why everything starts with great culture

Molecule to Market: Inside the outsourcing space ·

2022/09/08

In this special repurposed episode of Molecule to Market, we go back inside the global drug development space with previous guests Magnus Gustafsson, Board Member at Genovis, Jeff Dill, CEO at Vynamic. , and Peter Soelkner, Managing Director at Vetter to hear their thoughts on building a great organisational culture. Your host, Raman Sehgal, revisits discussions from past episodes, with amazing global guests who share their insights about building culture to give our listeners loads of takeaway

en

57:46

The orphan drug entrepreneur

Molecule to Market: Inside the outsourcing space ·

2022/08/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Evelyn Kelly, Chief Executive Officer at Orphan Drug Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Evelyn, covering: A deep dive into the world of orphan drugs, rare diseases and personalised medicines including the background, evolution and fast growth of the area. The revolution in drug development that we are living

en

248 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter